Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Abpro Bio Co., Ltd.
  6. News
  7. Summary
    A195990   KR7195990007

ABPRO BIO CO., LTD.

(A195990)
End-of-day quote Korea Stock Exchange  -  2022-11-24
529.00 KRW   -0.56%
09/26Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.
CI
2021Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding

12/24/2021 EST

On December 24, 2021, Abpro Bio Co., Ltd. closed the transaction. The company amended the terms of the transaction and issued 7,159,904 shares at a price of KRW 838 for gross proceeds of KRW 5,999,999,552. The transaction involved participation from returning investor Veritas Fund.


ę S&P Capital IQ 2021
All news about ABPRO BIO CO., LTD.
09/26Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul ..
CI
2021Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in fund..
CI
2021Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Merit..
CI
2021Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from..
CI
2020KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro..
CI
2020Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in ..
CI
2020Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea..
CI
2020Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billi..
CI
2020An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpr..
CI
More news
Financials
Sales 2021 32 914 M 24,7 M 24,7 M
Net income 2021 -10 030 M -7,51 M -7,51 M
Net cash 2021 32 581 M 24,4 M 24,4 M
P/E ratio 2021 -22,3x
Yield 2021 -
Capitalization 145 B 108 M 108 M
EV / Sales 2020 8,97x
EV / Sales 2021 6,42x
Nbr of Employees 47
Free-Float 90,5%
Chart ABPRO BIO CO., LTD.
Duration : Period :
Abpro Bio Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABPRO BIO CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Pui Chan Ian Yan Co-Chief Executive Officer & Director
Jin-Sang Yang Co-Chief Executive Officer & Director
Jae-Hong Jeon Independent Director
Gab-Jin Kang Independent Director
Ki-Chul An Independent Director